Yannick Müller

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


81 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010 | 2009 |
 
Rebalancing the Immune System to Treat Type 1 Diabetes.
Muller Y.D., Ho P., Bluestone J.A., Tang Q. Cold Spring Harbor perspectives in medicine. Peer-reviewed.
 
Features of chronic urticaria after COVID-19 mRNA vaccine over time.
Schwab J., Foglierini M., Pescosolido E., Pacheco I., Ruiz Buendía G.A., Madelon N., Pellaton C., Banderet V., Ribi C., Bergmann M.M. et al., 2024/11/30. Communications medicine, 4 (1) p. 254. Peer-reviewed.
RAIN: machine learning-based identification for HIV-1 bNAbs.
Foglierini M., Nortier P., Schelling R., Winiger R.R., Jacquet P., O'Dell S., Demurtas D., Mpina M., Lweno O., Muller Y.D. et al., 2024/06/24. Nature communications, 15 (1) p. 5339. Peer-reviewed.
 
Comprendre les réactions d’hypersensibilité aux anticorps monoclonaux [Understanding hypersensitivity reactions to monoclonal antibodies]
Cattaneo V., Belkoniene M., Porret R., Harr T., Muller Y.D., 2024/04/03. Revue medicale suisse, 20 (868) pp. 705-710. Peer-reviewed.
 
Thérapie cellulaire CAR-T dans le traitement des maladies auto-immunes [CAR-T therapy for autoimmune diseases]
Alcaraz-Serna A., Porret R., Trueb L., Ribi C., Seebach J., Muller Y.D., 2024/04/03. Revue medicale suisse, 20 (868) pp. 688-693. Peer-reviewed.
Residual Partial Least Squares Learning: Brain Cortical Thickness Simultaneously Predicts Eight Non-pairwise-correlated Behavioural and Disease Outcomes in Alzheimer's Disease.
Chén O.Y., Vũ D.T., Diaz C.S., Bodelet J.S., Phan H., Allali G., Nguyen V.D., Cao H., He X., Müller Y. et al., 2024/03/27..
Risk factors for allergy documentation in electronic health record: A retrospective study in a tertiary health center in Switzerland.
Ringwald M., Moi L., Wetzel A., Comte D., Muller Y.D., Ribi C., 2024/01. Allergology international, 73 (1) pp. 143-150. Peer-reviewed.
Lymph node dendritic cells harbor inducible replication-competent HIV despite years of suppressive ART.
Banga R., Procopio F.A., Lana E., Gladkov G.T., Roseto I., Parsons E.M., Lian X., Armani-Tourret M., Bellefroid M., Gao C. et al., 2023/10/11. Cell host & microbe, 31 (10) pp. 1714-1731.e9. Peer-reviewed.
Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines.
Alcaraz-Serna A., Noto A., Ermellino L., Monzambani-Banderet V., Tommasini F., Stehlin F., Girard C., Perreau M., Muller Y.D., 2023/10. Allergology international, 72 (4) pp. 600-603. Peer-reviewed.
Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients.
Fallet B., Foglierini M., Porret R., Alcaraz-Serna A., Sauvage C., Jenelten R., Caplanusi T., Gilliet M., Perez L., Fenwick C. et al., 2023/08. The Journal of infection, 87 (2) pp. 111-119. Peer-reviewed.
The Statistical Analysis of the Varying Brain.
Chén Oliver Y., Thanh Vũ Duy, Greub Gilbert, Cao Hengyi, He Xingru, Muller Yannick, Petrovas Constantinos, Shou Haochang, Nguyen Viet-Dung, Zhi Bangdong et al., 2023/07/02. IEEE Statistical Signal Processing (SSP). Peer-reviewed.
Hypersensibilité aux venins d’hyménoptères : le point en 2023 [Hymenoptera venom allergy: what's new in 2023]
Belkoniene M., Ringwald M., Leimgruber A., Muller Y.D., 2023/04/05. Revue medicale suisse, 19 (821) pp. 663-667. Peer-reviewed.
Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines.
Stehlin F., Tommasini F., Monzambani-Banderet V., Girard C., Yerly D., Ribi C., Muller Y.D., 2023/04. Allergology international, 72 (2) pp. 332-334. Peer-reviewed.
Incidence of Chronic Spontaneous Urticaria Following Receipt of the COVID-19 Vaccine Booster in Switzerland.
Duperrex O., Tommasini F., Muller Y.D., 2023/02/01. JAMA network open, 6 (2) pp. e2254298. Peer-reviewed.
Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation.
Ballou C., Barton F., Payne E.H., Berney T., Villard J., Meier RPH, Baidal D., Alejandro R., Robien M., Eggerman T.L. et al., 2023. Frontiers in immunology, 14 p. 1110544. Peer-reviewed.
 
Regulatory T cell homeostasis: Requisite signals and implications for clinical development of biologics.
Skartsis N., Muller Y.D., Ferreira LMR, 2023/01. Clinical immunology, 246 p. 109201. Peer-reviewed.
 
Rapid onset of chronic urticaria after Moderna COVID-19 booster vaccine
Olivier Duperrex, Francesco Tommasini, Yannick Muller, 2022/11/04..
 
Clinical and immunological data from chronic urticaria onset after mRNA SARS-CoV-2 vaccines.
Pescosolido E., Muller Y.D., Sabaté-Brescó M., Ferrer M., Yerly D., Caubet J.C., Lantin J.P., Ribi C., Bergmann M.M., 2022/11. Clinical and experimental allergy, 52 (11) pp. 1343-1346. Peer-reviewed.
Maladies causées par Anisakis simplex chez l’humain [Human diseases caused by Anisakis simplex]
Ringwald M., Muller Y.D., Ribi C., 2022/04/06. Revue medicale suisse, 18 (776) pp. 634-638.
Réactions d’hypersensibilité au fer intraveineux : le point de vue de l’allergologue [Hypersensitivity reactions to intravenous iron: an allergist' perspective]
Moi L., Stehlin F., Desseauve D., Ribi C., Muller Y.D., 2022/04/06. Revue medicale suisse, 18 (776) pp. 639-645. Peer-reviewed.
Atopy as an independent predictor for long-term patient and graft survival after kidney transplantation.
Porret R., Meier RPH, Mikulic J., Pascual M., Aubert V., Harr T., Golshayan D., Muller Y.D., 2022. Frontiers in immunology, 13 p. 997364. Peer-reviewed.
Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance.
Stehlin F., Mahdi-Aljedani R., Canton L., Monzambani-Banderet V., Miauton A., Girard C., Kammermann K., Meylan S., Ribi C., Harr T. et al., 2022. Frontiers in allergy, 3 p. 818049. Peer-reviewed.
Management of Beta-Lactam Antibiotics Allergy: A Real-Life Study.
Iuliano S., Senn L., Moi L., Muller Y.D., Ribi C., Buss G., Comte D., 2022. Frontiers in allergy, 3 p. 853587. Peer-reviewed.
 
Xenotransplantation: A New Era.
Carrier A.N., Verma A., Mohiuddin M., Pascual M., Muller Y.D., Longchamp A., Bhati C., Buhler L.H., Maluf D.G., Meier RPH, 2022. Frontiers in immunology, 13 p. 900594. Peer-reviewed.
Prevalence of large vessel vasculitis in ANCA-associated vasculitis: a retrospective cohort study.
Coattrenec Y., Muller Y.D., Spoerl D., Lobrinus J.A., Seebach J.D., 2021/12. Rheumatology international, 41 (12) pp. 2147-2156.
Vaccins à ARN messager contre le Covid-19 : piqûre de rappel [mRNA Covid vaccines: What do we know eight months after deployment]
Miauton A., Besson J., Muller Y., Genton B., 2021/11/10. Revue medicale suisse, 17 (758) pp. 1910-1914. Peer-reviewed.
 
Precision engineering of an anti-HLA-A2 chimeric antigen receptor in regulatory T cells for transplant immune tolerance
Muller Yannick D., Ferreira Leonardo M.R., Ronin Emilie, Ho Patrick, Nguyen Vinh, Faleo Gaetano, Zhou Yu, Lee Karim, Leung Kevin K., Skartsis Nikolaos et al., 2021/08/17..
 
Recent progress and remaining hurdles toward clinical xenotransplantation.
Meier RPH, Longchamp A., Mohiuddin M., Manuel O., Vrakas G., Maluf D.G., Buhler L.H., Muller Y.D., Pascual M., 2021/05. Xenotransplantation, 28 (3) pp. e12681. Peer-reviewed.
Une allergie insolite : le syndrome cannabis-fruits et legumes [An unusual allergy : cannabis-fruit and vegetable syndrome]
Ringwald M., Moi L., Muller Y.D., Ribi C., 2021/04/07. Revue medicale suisse, 17 (733) pp. 680-683. Peer-reviewed.
 
Vaccins contre le Covid-19 : cibles vaccinales, immunogénicité et réactions allergiques [COVID-19 vaccines: vaccine targets, immunogenicity and allergic reactions]
Fallet B., Miauton A., Comte D., Ribi C., Muller Y.D., 2021/04/07. Revue medicale suisse, 17 (733) pp. 690-696.
 
Chimeric antigen receptor T-cell therapy for HIV cure.
Alfageme-Abello O., Porret R., Perreau M., Perez L., Muller Y.D., 2021/03/01. Current opinion in HIV and AIDS, 16 (2) pp. 88-97. Peer-reviewed.
 
Immunologic Clearance of a BK Virus-associated Metastatic Renal Allograft Carcinoma.
Meier RPH, Muller Y.D., Dietrich P.Y., Tille J.C., Nikolaev S., Sartori A., Labidi-Galy I., Ernandez T., Kaur A., Hirsch H.H. et al., 2021/02/01. Transplantation, 105 (2) pp. 423-429. Peer-reviewed.
 
CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles' Heel?
Ferreira LMR, Muller Y.D., 2021. Frontiers in immunology, 12 p. 766220. Peer-reviewed.
 
IL-6 and TNFα Drive Extensive Proliferation of Human Tregs Without Compromising Their Lineage Stability or Function.
Skartsis N., Peng Y., Ferreira LMR, Nguyen V., Ronin E., Muller Y.D., Vincenti F., Tang Q., 2021. Frontiers in immunology, 12 p. 783282. Peer-reviewed.
 
Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
Muller Y.D., Ferreira LMR, Ronin E., Ho P., Nguyen V., Faleo G., Zhou Y., Lee K., Leung K.K., Skartsis N. et al., 2021. Frontiers in immunology, 12 p. 686439. Peer-reviewed.
 
Revaccination of persons with an immediate reaction after the first dose of mRNA COVID-19 vaccine
Stehlin F., Canton L., Girard C., Miauton A., Santos A., Genoud P., Ribi C., Meylan S., Muller Y. D., 2021. pp. 516-517 dans Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 10-12 July 2021, Allergy.
The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28.
Muller Y.D., Nguyen D.P., Ferreira LMR, Ho P., Raffin C., Valencia RVB, Congrave-Wilson Z., Roth T.L., Eyquem J., Van Gool F. et al., 2021. Frontiers in immunology, 12 p. 639818. Peer-reviewed.
 
TNFa and IL-6 promote ex-vivo proliferation of lineage-committed human regulatory T cells
Skartsis Nikolaos, Peng Yani, Ferreira Leonardo M.R., Nguyen Vinh, Muller Yannick, Vincenti Flavio, Tang Qizhi, 2021..
 
Pancreas collagen digestion during islet of Langerhans isolation-a prospective study.
Meier RPH, Meyer J., Muller Y.D., Szot G.L., Bédat B., Andres A., Massé N., Lablanche S., Puppa G., Bosco D. et al., 2020/11. Transplant international, 33 (11) pp. 1516-1528. Peer-reviewed.
The Inhibition of Complement System in Formal and Emerging Indications: Results from Parallel One-Stage Pairwise and Network Meta-Analyses of Clinical Trials and Real-Life Data Studies.
Bernuy-Guevara C., Chehade H., Muller Y.D., Vionnet J., Cachat F., Guzzo G., Ochoa-Sangrador C., Álvarez F.J., Teta D., Martín-García D. et al., 2020/09/16. Biomedicines, 8 (9) pp. E355. Peer-reviewed.
 
Prolongation of rat-to-mouse islets xenograft survival by co-transplantation of autologous IL-10 differentiated murine tolerogenic dendritic cells.
Madelon N., Montanari E., Gruaz L., Pimenta J., Muller Y.D., Bühler L.H., Puga Yung G.L., Seebach J.D., 2020/07. Xenotransplantation, 27 (4) pp. e12584. Peer-reviewed.
Management of allergy transfer upon solid organ transplantation.
Muller Y.D., Vionnet J., Beyeler F., Eigenmann P., Caubet J.C., Villard J., Berney T., Scherer K., Spertini F., Fricker M.P. et al., 2020/03. American journal of transplantation, 20 (3) pp. 834-843. Peer-reviewed.
 
Next-generation regulatory T cell therapy.
Ferreira LMR, Muller Y.D., Bluestone J.A., Tang Q., 2019/10. Nature reviews. Drug discovery, 18 (10) pp. 749-769. Peer-reviewed.
 
Targeting Laminin 511, a New Pathway to Promote Organ Tolerance?
Muller Y.D., Meier RPH, 2019/10. Transplantation, 103 (10) pp. 1982-1983. Peer-reviewed.
 
Interleukin-1 Receptor Antagonist Modulates Liver Inflammation and Fibrosis in Mice in a Model-Dependent Manner.
Meier RPH, Meyer J., Montanari E., Lacotte S., Balaphas A., Muller Y.D., Clément S., Negro F., Toso C., Morel P. et al., 2019/03/14. International journal of molecular sciences, 20 (6). Peer-reviewed.
 
Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier
Esensten Jonathan H., Muller Yannick D., Bluestone Jeffrey A., Tang Qizhi, 2018/12. Journal of Allergy and Clinical Immunology, 142 (6) pp. 1710-1718.
 
Pancreas preservation fluid microbial contamination is associated with poor islet isolation outcomes - a multi-centre cohort study.
Meier RPH, Andrey D.O., Sun P., Niclauss N., Bédat B., Demuylder-Mischler S., Borot S., Benhamou P.Y., Wojtusciszyn A., Buron F. et al., 2018/08. Transplant international, 31 (8) pp. 917-929. Peer-reviewed.
Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.
Muller Y.D., Aubert J.D., Vionnet J., Rotman S., Sadallah S., Aubert V., Pascual M., 2018/06. Transplantation, 102 (6) pp. e301-e303. Peer-reviewed.
 
Xenotransplantation: back to the future?
Meier RPH, Muller Y.D., Balaphas A., Morel P., Pascual M., Seebach J.D., Buhler L.H., 2018/05. Transplant international, 31 (5) pp. 465-477. Peer-reviewed.
 
C1 esterase inhibitor concentrates and attenuated androgens.
Muller Y.D., Harr T., Dayer E., Seebach J.D., 2018/04/07. Lancet, 391 (10128) pp. 1355-1356. Peer-reviewed.
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.
Muller Y.D., Ghaleb N., Rotman S., Vionnet J., Halfon M., Catana E., Golshayan D., Venetz J.P., Aubert V., Pascual M., 2018/04. Transplant international, 31 (4) pp. 451-455. Peer-reviewed.
 
Loss of end-differentiated β-cell phenotype following pancreatic islet transplantation.
Anderson S.J., White M.G., Armour S.L., Maheshwari R., Tiniakos D., Muller Y.D., Berishvili E., Berney T., Shaw JAM, 2018/03. American journal of transplantation, 18 (3) pp. 750-755. Peer-reviewed.
 
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation [PLB069]
Muller Y, Ghaleb N., Rotman S, Catana E., Golshayan D, Venetz JP, Aubert V., Pascual M., 2017/10/31. pp. 553-554 dans Transplant International.
 
Contributing Factors and Impact of Microbial Contamination in Human Islet Isolation and Transplantation
Meier R., Andrey D., Niclauss N., Sun P., Van Delden C., Bedat B., Demuylder-Mischler S., Borot S., Benhamou P. Y., Wojtusciszyn A. et al., 2017/09. pp. 353-353 dans Transplant International.
 
Artérites des grands vaisseaux : pathogenèse, diagnostic et prise en charge [Large vessel vasculitis : pathogenesis, diagnostic and medical management]
Sadrkhah A., Seebach J.D., Muller Y., 2017/04/05. Revue medicale suisse, 13 (557) pp. 758-762. Peer-reviewed.
 
Contributing Factors and Impact of Microbial Contamination in Human Islet Isolation and Transplantation
Meier R., Andrey D., Niclauss N., Sun P., van Delden C., Bedat B., Demuylder-Mischler S., Borot S., Benhamou P. Y., Wojtusciszyn A. et al., 2017/04. pp. 693-693 dans American Journal of Transplantation.
 
TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature.
Louis C., Vijgen S., Samii K., Chalandon Y., Terriou L., Launay D., Fajgenbaum D.C., Seebach J.D., Muller Y.D., 2017. Frontiers in medicine, 4 p. 149. Peer-reviewed.
 
Hereditary haemorrhagic telangiectasia: to transplant or not to transplant - is there a right time for liver transplantation?
Muller Y.D., Oppliger R., Breguet R., Meyer P., Rubbia-Brandt L., Petignat P.A., Harr T., Dayer E., Seebach J.D., 2016/12. Liver international, 36 (12) pp. 1735-1740. Peer-reviewed.
 
Chemoattractant Signals and Adhesion Molecules Promoting Human Regulatory T Cell Recruitment to Porcine Endothelium.
Ehirchiou D., Muller Y.D., Chicheportiche R., Heyrani Nobari R., Madelon N., Schneider M.K., Seebach J.D., 2016/04. Transplantation, 100 (4) pp. 753-762. Peer-reviewed.
 
Allergologie. Traitement de l'angiœdème à bradykinine non héréditaire d'origine médicamenteuse [Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin]
Muller Y., Harr T., 2016/01/13. Revue medicale suisse, 12 (500) pp. 11-12. Peer-reviewed.
 
Allergies et effets indésirabtes dus aux fluoroquinolones [Allergies and adverse events associated with fluoroquinolones]
Muller Y., Andrey D., Emonet S., Harr T., Spoerl D., 2015/04/08. Revue medicale suisse, 11 (469) pp. 826-830. Peer-reviewed.
 
Absence of amyloid deposition in human islets transplantation after 13 years insulin independence.
Muller Y.D., Morel P., Berney T., 2015/04. Transplantation, 99 (4) pp. e31-2. Peer-reviewed.
 
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice.
Meier R.P., Mahou R., Morel P., Meyer J., Montanari E., Muller Y.D., Christofilopoulos P., Wandrey C., Gonelle-Gispert C., Bühler L.H., 2015/03. Journal of hepatology, 62 (3) pp. 634-641. Peer-reviewed.
 
Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade.
Giovannoni L., Muller Y.D., Lacotte S., Parnaud G., Borot S., Meier R.P., Lavallard V., Bédat B., Toso C., Daubeuf B. et al., 2015/01. Transplantation, 99 (1) pp. 29-35. Peer-reviewed.
 
Islet of Langerhans isolation from pediatric and juvenile donor pancreases.
Meier R.P., Sert I., Morel P., Muller Y.D., Borot S., Badet L., Toso C., Bosco D., Berney T., 2014/09. Transplant international, 27 (9) pp. 949-955. Peer-reviewed.
 
Transplantation cellulaire: traitements actuels et perspectives d'avenir [Cell transplantation: current treatments and future prospects]
Meier R.P., Muller Y.D., Gutzwiller E.M., Spahr L., Negro F., Krause K.H., Schaller K., Wandrey C., Sgroi A., Morel P. et al., 2014/06/18. Revue medicale suisse, 10 (435) pp. 1350-1355. Peer-reviewed.
Survival of free and encapsulated human and rat islet xenografts transplanted into the mouse bone marrow.
Meier R.P., Seebach J.D., Morel P., Mahou R., Borot S., Giovannoni L., Parnaud G., Montanari E., Bosco D., Wandrey C. et al., 2014. PloS one, 9 (3) pp. e91268. Peer-reviewed.
 
Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence?
Meier R.P., Müller Y.D., Morel P., Gonelle-Gispert C., Bühler L.H., 2013/11. Stem cell research, 11 (3) pp. 1348-1364. Peer-reviewed.
 
Quantification of islet loss and graft functionality during immune rejection by 3-tesla MRI in a rat model.
Borot S., Crowe L.A., Parnaud G., Ris F., Meier R., Giovannoni L., Müller Y.D., Lacotte S., Morel P., Toso C. et al., 2013/09/15. Transplantation, 96 (5) pp. 438-444. Peer-reviewed.
 
Literature Watch: implications for transplantation.
Muller Y.D., Meier R.P., Bromberg J.S., Bühler L.H., 2013/06. American journal of transplantation, 13 (6) p. 1377. Peer-reviewed.
 
Transplanted human pancreatic islets after long-term insulin independence.
Muller Y.D., Gupta S., Morel P., Borot S., Bettens F., Truchetet M.E., Villard J., Seebach J.D., Holmberg D., Toso C. et al., 2013/04. American journal of transplantation, 13 (4) pp. 1093-1097. Peer-reviewed.
 
Cadherin engagement protects human β-cells from apoptosis.
Parnaud G., Gonelle-Gispert C., Morel P., Giovannoni L., Muller Y.D., Meier R., Borot S., Berney T., Bosco D., 2011/12. Endocrinology, 152 (12) pp. 4601-4609. Peer-reviewed.
 
Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network.
Borot S., Niclauss N., Wojtusciszyn A., Brault C., Demuylder-Mischler S., Müller Y., Giovannoni L., Parnaud G., Meier R., Badet L. et al., 2011/11/15. Transplantation, 92 (9) pp. 1031-1038. Peer-reviewed.
 
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.
Ellingsgaard H., Hauselmann I., Schuler B., Habib A.M., Baggio L.L., Meier D.T., Eppler E., Bouzakri K., Wueest S., Muller Y.D. et al., 2011/10/30. Nature medicine, 17 (11) pp. 1481-1489. Peer-reviewed.
 
Islet autotransplantation after extended pancreatectomy for focal benign disease of the pancreas.
Ris F., Niclauss N., Morel P., Demuylder-Mischler S., Muller Y., Meier R., Genevay M., Bosco D., Berney T., 2011/04/27. Transplantation, 91 (8) pp. 895-901. Peer-reviewed.
 
Influence of donor age on islet isolation and transplantation outcome.
Niclauss N., Bosco D., Morel P., Demuylder-Mischler S., Brault C., Milliat-Guittard L., Colin C., Parnaud G., Muller Y.D., Giovannoni L. et al., 2011/02/15. Transplantation, 91 (3) pp. 360-366. Peer-reviewed.
 
Transplantation tolerance: Clinical potential of regulatory T cells.
Muller Y.D., Seebach J.D., Bühler L.H., Pascual M., Golshayan D., 2011. Self/nonself, 2 (1) pp. 26-34.
Anti-CD154 mAb and rapamycin induce T regulatory cell mediated tolerance in rat-to-mouse islet transplantation.
Muller Y.D., Mai G., Morel P., Serre-Beinier V., Gonelle-Gispert C., Yung G.P., Ehirchiou D., Wyss J.C., Bigenzahn S., Irla M. et al., 2010/04/26. PloS one, 5 (4) pp. e10352. Peer-reviewed.
 
Unique arrangement of α- and β-cells in human islets of Langerhans
Müller Yannick, 2010. Diabetes.
 
Anti-CD154 mAb and rapamycin induce T regulatory cell mediated tolerance in xenogeneic islet transplantation : IXA-O-1.2
Muller Yannick, Morel Philippe, Golshayan Déla, Seebach Jörg, Wekerle Thomas, Bühler Léo, 2009. p. 353 dans Joint Meeting of the International-Pancreas-and-Islet-Transplant-Association/International-Xenotransplantation-Association, Xenotransplantation. Peer-reviewed.
 
T regulatory cells in xenotransplantation.
Muller Y.D., Golshayan D., Ehirchiou D., Wekerle T., Seebach J.D., Bühler L.H., 2009. Xenotransplantation, 16 (3) pp. 121-128. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University